While Studies on COVID-19 Vaccine is Ongoing, the Public's Thoughts and Attitudes to the Future COVID-19 Vaccine

Overview

Journal Int J Clin Pract

Publisher Wiley

Specialty General Medicine

Date 2020 Dec 5

PMID 33278857

Citations 102

Authors

Busra Akarsu

Dilara Canbay Ozdemir

Duygu Ayhan Baser

Hilal Aksoy

Izzet Fidanci

Mustafa Cankurtaran

Affiliations

Soon will be listed here.

Abstract

Objective: In this study, we aim to investigate the thoughts and attitudes of individuals towards the future COVID-19 vaccine.

Methods: This descriptive study was carried out on the web between 10/06/2020 and 10/07/2020. The sample constitutes all individuals above 18 years of age using social media and smartphone. The e-survey form was shared by the researchers via the web for a month, and those who completed the survey were included in the study and formed the sample of the research.

Results: Seven-hundred and fifty-nine people participated. 49.7% of the participants stated to be vaccinated; 38.4% of them stated to be vaccinated their children against COVID-19; if the vaccine for COVID-19 is developed. The request for the COVID-19 vaccine had relationship with gender, occupation, health insurance, anxiety level, having children and willing to get vaccinated for their children. "Afraid of the side effects of vaccine", "don't think it can be reliable as it will be a new vaccine" and "COVID-19 infection is a biological weapon and the vaccine will serve those who produce this virus" were the most common reasons for rejection of vaccine.

Conclusion: In our study, afraid of the side effects of vaccine and not thinking it can be reliable as it will be a new vaccine are the most reasons of indecision and rejection about COVID 19 vaccine. In order for the future COVID 19 vaccination campaign to not fail, media, politicians and healthcare professionals should closely follow the vaccination development processes, inform the public transparently and consider public's concerns.

Citing Articles

How People in Eight European Countries Felt About the Safety, Effectiveness, and Necessity of COVID-19 Vaccination: A Cross-Sectional Survey.

Coteur K, Zafirovska M, Zafirovski A, Danilenko J, Lingner H, Bauch F Healthcare (Basel). 2025; 13(3).

PMID: 39942533 PMC: 11817506. DOI: 10.3390/healthcare13030344.

The individual and ecological characteristics of parental COVID-19 vaccination decisions.

Hornig L, Schaffner S, Schmitz H Sci Rep. 2024; 14(1):24194.

PMID: 39406956 PMC: 11480482. DOI: 10.1038/s41598-024-74963-8.

COVID-19 vaccination rates and factors affecting vaccination in children with rheumatic disease.

Aydin T, Baykal G, Karagol C, Haslak F, Vazgecer E, Torun R Arch Rheumatol. 2024; 39(2):221-231.

PMID: 38933728 PMC: 11196226. DOI: 10.46497/ArchRheumatol.2024.10356.

Survival Analysis and Socio-Cognitive Factors in the Timing of COVID-19 Vaccination Among Mexican-Origin Youth.

Kim S, Wen W, Coulter K, Du Y, Tse H, Hou Y J Racial Ethn Health Disparities. 2024; .

PMID: 38580808 DOI: 10.1007/s40615-024-01995-1.

The Impact of the Successive Outbreaks of COVID-19, Vaccination, and Physical Activity on Mental Health in the Argentine Population: A Repeated Cross-Sectional Study.

Barbuzza A, Ballarini F, Goyeneche C, Reppucci V, Benedetti P, Moscato F Cureus. 2024; 16(2):e54932.

PMID: 38544624 PMC: 10966936. DOI: 10.7759/cureus.54932.

References

Bish A, Yardley L, Nicoll A, Michie S . Factors associated with uptake of vaccination against pandemic influenza: a systematic review. Vaccine. 2011; 29(38):6472-84. DOI: 10.1016/j.vaccine.2011.06.107. View

Guan W, Ni Z, Hu Y, Liang W, Ou C, He J . Clinical Characteristics of Coronavirus Disease 2019 in China. N Engl J Med. 2020; 382(18):1708-1720. PMC: 7092819. DOI: 10.1056/NEJMoa2002032. View

Le T, Andreadakis Z, Kumar A, Roman R, Tollefsen S, Saville M . The COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020; 19(5):305-306. DOI: 10.1038/d41573-020-00073-5. View

Sevencan F, Ertem M, Ozcullu N, Dorman V, Kubat N . The evaluation of the opinions and attitudes of healthcare personnel of the province Diyarbakir against influenza A (H1N1) and the vaccination. Hum Vaccin. 2011; 7(9):945-51. DOI: 10.4161/hv.7.9.16368. View

Corey L, Mascola J, Fauci A, Collins F . A strategic approach to COVID-19 vaccine R&D. Science. 2020; 368(6494):948-950. DOI: 10.1126/science.abc5312. View

Drasch G, Aigner S, Roider G, Staiger F, Lipowsky G . Mercury in human colostrum and early breast milk. Its dependence on dental amalgam and other factors. J Trace Elem Med Biol. 1998; 12(1):23-7. DOI: 10.1016/s0946-672x(98)80017-5. View

Giannattasio A, Mariano M, Romano R, Chiatto F, Liguoro I, Borgia G . Sustained low influenza vaccination in health care workers after H1N1 pandemic: a cross sectional study in an Italian health care setting for at-risk patients. BMC Infect Dis. 2015; 15:329. PMC: 4533948. DOI: 10.1186/s12879-015-1090-x. View

Asmundson G, Taylor S . How health anxiety influences responses to viral outbreaks like COVID-19: What all decision-makers, health authorities, and health care professionals need to know. J Anxiety Disord. 2020; 71:102211. PMC: 7271220. DOI: 10.1016/j.janxdis.2020.102211. View

Chan E, Cheng C, Tam G, Huang Z, Lee P . Willingness of future A/H7N9 influenza vaccine uptake: A cross-sectional study of Hong Kong community. Vaccine. 2015; 33(38):4737-40. DOI: 10.1016/j.vaccine.2015.07.046. View

10.

Arda B, Durusoy R, Yamazhan T, Sipahi O, Tasbakan M, Pullukcu H . Did the pandemic have an impact on influenza vaccination attitude? A survey among health care workers. BMC Infect Dis. 2011; 11:87. PMC: 3084177. DOI: 10.1186/1471-2334-11-87. View

11.

Hessel L . [Mercury in vaccines]. Bull Acad Natl Med. 2004; 187(8):1501-10. View

12.

Xu K, Cai H, Shen Y, Ni Q, Chen Y, Hu S . [Management of COVID-19: the Zhejiang experience]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2020; 49(2):147-157. PMC: 8800711. DOI: 10.3785/j.issn.1008-9292.2020.02.02. View

13.

Ball L, Ball R, Pratt R . An assessment of thimerosal use in childhood vaccines. Pediatrics. 2001; 107(5):1147-54. DOI: 10.1542/peds.107.5.1147. View

14.

Hou Z, Chang J, Yue D, Fang H, Meng Q, Zhang Y . Determinants of willingness to pay for self-paid vaccines in China. Vaccine. 2014; 32(35):4471-4477. DOI: 10.1016/j.vaccine.2014.06.047. View

15.

Ormen B, Turker N, Vardar I, Kaptan F, El S, Ural S . [Attitudes and side effects related to pandemic influenza A (H1N1) vaccination in healthcare personnel]. Mikrobiyol Bul. 2012; 46(1):57-64. View

16.

Shaw C, Tomljenovic L . Aluminum in the central nervous system (CNS): toxicity in humans and animals, vaccine adjuvants, and autoimmunity. Immunol Res. 2013; 56(2-3):304-16. DOI: 10.1007/s12026-013-8403-1. View

17.

Orbach H, Agmon-Levin N, Zandman-Goddard G . Vaccines and autoimmune diseases of the adult. Discov Med. 2010; 9(45):90-7. View

18.

Akarsu B, Canbay Ozdemir D, Ayhan Baser D, Aksoy H, Fidanci I, Cankurtaran M . While studies on COVID-19 vaccine is ongoing, the public's thoughts and attitudes to the future COVID-19 vaccine. Int J Clin Pract. 2020; 75(4):e13891. PMC: 7883065. DOI: 10.1111/ijcp.13891. View

19.

Dube E, Laberge C, Guay M, Bramadat P, Roy R, Bettinger J . Vaccine hesitancy: an overview. Hum Vaccin Immunother. 2013; 9(8):1763-73. PMC: 3906279. DOI: 10.4161/hv.24657. View

20.

Wood J . Developing vaccines against pandemic influenza. Philos Trans R Soc Lond B Biol Sci. 2002; 356(1416):1953-60. PMC: 1088574. DOI: 10.1098/rstb.2001.0981. View